WELL Health Announces Appointment of Senior Vice President, Capital Markets
Jamil Nathoo, an executive with over 16 years of experience in the financial industry, to lead WELL’s expansion into U.S. capital markets.
VANCOUVER, BC, June 29, 2021 / PRNewswire / – WELL Health Technologies Corp. (TSX: WELL) (“GOOD“or the”Company“), a company focused on consolidating and modernizing clinical and digital assets in healthcare, today announced the recent appointment of Jamil Nathoo as Senior Vice President of Capital Markets at WELL. Previously, Jamil spent the last six years at Goldman Sachs as Managing Director responsible for structured debt distribution. Jamil joined Goldman Sachs in 2015 as Vice President of the Investment Banking division and appointed Managing Director in 2019.
Hamed Chahbazi, President and CEO of WELL Health said, “We are very pleased that Jamil is joining us as the company’s senior vice president of capital markets, bringing to WELL over 16 years serving three of the world’s largest full-service investment banks. , his extensive buy-side and sell-side experience, coupled with his proven ability to lead in the ever-changing business environment and fast-paced capital markets, will provide considerable navigational support to WELL’s own growth strategies as it engages with the US capital markets. ”
Prior to Goldman Sachs, Jamil worked as a director at BNP Paribas, where he helped launch the company’s structured credit distribution and secured loan bond (CLO) business. Jamil has led global marketing and syndication at BNP Paribas. Prior to that, he was Vice President of Deutsche Bank for three years in Structured Product Sales. Earlier in his career, Jamil worked on the long side of bond trading at ACA Capital. Jamil obtained his bachelor’s degree in economics from University of Western Ontario and his MBA in Finance and Marketing from HEC Paris.
“I am delighted to be a part of the incredible WELL team and to lead the expansion of the company’s financial markets,” said Jamil. “I believe the goal-oriented work of WELL to evolve healthcare through the modernization of patient services and the empowerment of practitioners, combined with the formidable growth and disciplined acquisition strategy of WELL , positions WELL as an attractive opportunity for the world’s largest financial markets. ”
Virtual Annual General Meeting
WELL is also pleased to invite shareholders to join the company’s virtual annual general meeting hosted by the Chairman and CEO, Hamed Chahbazi, which takes place today at 10:00 a.m. PST (1 p.m. EST). To join, go to: https://www.well.company/for-investors/events/
WELL HEALTH TECHNOLOGIES CORP.
Through: “Hamed Shahbazi”
Chairman and Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL is an omnichannel digital health company whose primary goal is to empower physicians to deliver the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates primary and executive health care clinics in both Canada and the United States, operates a global electronic medical records (EMR) business serving thousands of health clinics and health systems of all sizes and operates a multinational portfolio of telehealth services that includes one of the largest telehealth service providers at Canada. WELL is also a provider of technology solutions related to digital health, billing and cybersecurity. WELL’s wholly owned subsidiary, CRH Medical, provides a variety of products and services that have supported thousands of gastroenterology physicians in the United States. WELL is an acquisition company that follows a disciplined and accretive capital allocation strategy. WELL is listed on the Toronto Stock Exchange under the symbol “GOODTo access the Society’s Canadian telehealth service, visit: tiahealth.com, and for company information, visit: www.well.company.
Notice Regarding Forward-Looking Statements
Certain statements contained in this press release concerning the Company are forward-looking statements and are forward-looking in nature, including the statement that: WELL engages with the US capital markets. Forward-looking statements are not based on historical facts, but rather on current expectations and projections regarding future events and are therefore subject to risks and uncertainties that could cause actual results to differ materially from future results. expressed or implied by forward-looking statements. . These statements can generally be identified by the use of forward-looking words such as “could”, “should”, “could”, “would intend”, “estimate”, “plan”, “anticipate”, “s’ expect “,” believe “,” work on “or” continue “, or the negative of these or similar variations. There are many risks and uncertainties that could cause WELL’s actual results and plans and objectives to differ materially from those expressed in forward-looking information, including: risks of business disruption related to COVID-19; regulatory risks, including those related to healthcare, and technology implementation risks, including those related to privacy and cybersecurity. Actual results and future events could differ materially from those anticipated in this information. This subsequent written and oral forward-looking information and all subsequent forward-looking information are based on management’s estimates and opinions on the dates on which they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
SOURCE WELL Health Technologies Corp.